IIM
LMAT icon

Illumine Investment Management’s LeMaitre Vascular LMAT Stock Holding History

Illumine Investment Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,874
Closed -$1.52M – 44
2026
Q1 		$1.62M Buy
14,874
+538
+4% +$51.3K 1.25% 26
2025
Q4 		$1.16M Buy
14,336
+304
+2% +$26.2K 0.85% 45
2025
Q3 		$1.23M Buy
14,032
+195
+1% +$17.4K 0.87% 44
2025
Q2 		$1.15M Buy
13,837
+321
+2% +$26.8K 0.91% 37
2025
Q1 		$1.13M Buy
13,516
+84
+0.6% +$7.81K 0.93% 38
2024
Q4 		$1.24M Buy
+13,432
New +$1.29M 1.02% 38

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Illumine Investment Management's LMAT Position: Q2 2026 in Review

Illumine Investment Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 14,874 shares — an estimated $1.52M sold.

Illumine Investment Management first reported a position in LMAT in Q4 2024 and held it in 6 quarters. The position peaked at $1.62M in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Illumine Investment Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Illumine Investment Management sold 14,874 LeMaitre Vascular shares in Q2 2026, an estimated $1.52M.
  • Illumine Investment Management first reported a position in LeMaitre Vascular in Q4 2024 and held it in 6 quarters.
  • Illumine Investment Management's LeMaitre Vascular position peaked at $1.62M in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Illumine Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.